Skip to main content
FinSpry Logo
FinSpry
NMRA logo
NMRA
(NASDAQ)
Neumora Therapeutics, Inc.
$1.53-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Neumora Therapeutics (NMRA) Stock Price & Financial Analysis

Neumora Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.51 - $1.65
52-Week High$3.65
52-Week Low$0.83
Open$1.58
Volume1.16M
Average Volume (3M)721.46K
Market Cap274.30M
Shares Outstanding179.87M
Price to Book (P/B)3.87
EV/EBITDA-0.58
50-Day MA$1.61
200-Day MA$2.15
52-Week Change-7.32%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Neumora Therapeutics

What is the current stock price for NMRA?

As of the latest trading session, NMRA stock trades at $1.52. The 52-week range is $0.83–$3.65, with a day range of $1.51–$1.65.

What is the P/E ratio for NMRA?

The P/E ratio (Price-to-Earnings) for NMRA is shown in the Key Statistics section. This valuation metric helps compare Neumora Therapeutics, Inc. to industry peers.

Does NMRA pay dividends?

Neumora Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NMRA?

Based on 6 analysts, the consensus for NMRA is Buy.

What is the market cap of NMRA?

Neumora Therapeutics's market capitalization is $274.3M, classifying it as a micro-cap company. Neumora Therapeutics operates in the Healthcare sector within the Biotechnology industry.